Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)

CMS evidence review | evidence_type=MEDCAC Meeting | record_type=medcac_meeting | document_id=25 | meeting_date=2004-09-28

The Centers for Medicare & Medicaid Services is reviewing its national coverage decision regarding the diagnosis of patients with OSA requiring CPAP therapy. Current national coverage guidelines specify that only a polysomnography done in a facility-based sleep study laboratory be used to identify patients with OSA requiring CPAP (CIM 60-17). CMS has received a Request [PDF, 78KB] from Dr Terence M. Davidson, MD, of the University of California San Diego, School of Medicine to modify this decision to include the use of portable multi-channel home sleep testing devices as an alternative to facility-based polysomnography in the evaluation of OSA.

Agenda: Federal Register Notice Associated Nca: Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) (CAG-00093R) Issue: The Centers for Medicare & Medicaid Services is reviewing its national coverage decision regarding the diagnosis of patients with OSA requiring CPAP therapy. Current national coverage guidelines specify that only a polysomnography done in a facility-based sleep study laboratory be used to identify patients with OSA requiring CPAP (CIM 60-17). CMS has received a Request [PDF, 78KB] from Dr Terence M. Davidson, MD, of the University of California San Diego, School of Medicine to modify this decision to include the use of portable multi-channel home sleep testing devices as an alternative to facility-based polysomnography in the evaluation of OSA. Minutes: Download Minutes [PDF, 464KB]. Other Material: Transcript 1 Panel Voting Questions: Download Qs and As [PDF, 45KB]. Roster: Chairperson Ron Davis, MD Center for Health Promotion and Disease Prevention Henry Ford Hospital Voting Members David C. Dale, MD University of Washington Department of Medicine A. Mark Fendrick, MD Internal Medicine and Health Management & Policy University of Michigan G. Scott Gazelle, MD, MPH, PhD Institute for Technology Assessment Massachusetts General Hospital Clifford Goodman. PhD The Lewin Group Alexander Krist, MD Fairfax Family Practice Residency Virginia Commonwealth University Michael Maves, MD, MBA American Medical Association Rita F. Redberg, MD, MSc, FACC Division of Cardiology UCSF School of Medicine Jonathan P. Weiner, PhD Division of Health Services Research, Johns Hopkins School of Public Health Consumer Representative Joan Samuelson Industry Representative Michael Lacey Boston Scientific Corporation Guest Panelists Robert D. Hoover, Jr., MD, MPH DMERC Region D CIGNA HealthCare Medicare Administration S. Satya-Murti, MD Region VII Kansas Blue Shield Barry Whites, MD, FCCP, MSHA Region IV TriSpan Health Services CMS Liaison Steve Phurrough, MD Director, Coverage and Analysis Group, Office of Clinical Standards and Quality, CMS Executive Secretary Janet Anderson Brock